AVITA Medical, Inc. (RCEL)
13.10
-0.26
(-1.95%)
USD |
NASDAQ |
Oct 14, 16:00
12.97
-0.13
(-0.99%)
Pre-Market: 20:00
AVITA Medical Total Long Term Debt (Quarterly) : 48.48M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 48.48M |
| March 31, 2026 | 48.12M |
| December 31, 2025 | 45.12M |
| September 30, 2025 | 44.77M |
| June 30, 2025 | 44.59M |
| March 31, 2025 | 44.07M |
| December 31, 2024 | 45.08M |
| September 30, 2024 | 45.63M |
| June 30, 2024 | 44.27M |
| March 31, 2024 | 43.83M |
| December 31, 2023 | 41.51M |
| September 30, 2023 | 1.845M |
| Date | Value |
|---|---|
| June 30, 2023 | 1.047M |
| March 31, 2023 | 1.235M |
| December 31, 2022 | 0.306M |
| September 30, 2022 | 0.405M |
| June 30, 2022 | 0.532M |
| March 31, 2022 | 0.726M |
| June 30, 2021 | 0.878M |
| March 31, 2021 | 1.06M |
| December 31, 2020 | 1.241M |
| September 30, 2020 | 1.783M |
| June 30, 2020 | 1.928M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Halozyme Therapeutics, Inc. | 2.147B |
| Iovance Biotherapeutics, Inc. | 43.33M |
| Agenus, Inc. | 259.00M |
| Amgen, Inc. | 57.30B |
| Editas Medicine, Inc. | 64.74M |